Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2010-04-26

FDA Approved: VIRACEPT — Supplemental Application (AGOURON)

View source ↗

Summary

FDA approved a supplemental application for Viracept (nelfinavir mesylate) submitted by Agouron, to the existing NDA NDA020779.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Viracept (Nelfinavir)

Snippet

SUPPL AP for VIRACEPT (NELFINAVIR MESYLATE)